First in-human (FIH) study on the Safety, Tolerability and Efficacy of the AquaMedical focal RF-vapor ablation (RFVA) system, for the eradication of Barrett's Esophagus (BE)

(1) Amsterdam UMC,Amsterdam,Netherlands

(2) St Antonius Hospital,Nieuwegein,Netherlands

This item was part of the Late breaking abstracts: Hot news from endoscopy session at UEG Week 2019

This item can be cited as: United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019